Sanara Medtech Inc
SMTI25.040USD
+0.830+3.43%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
223.63MMarket Cap
LossP/E TTM
More Details of Sanara Medtech Inc Company
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Sanara Medtech Inc Info
Ticker SymbolSMTI
Company nameSanara Medtech Inc
IPO dateApr 07, 1994
CEOMuppalla (Suresh V)
Number of employees141
Security typeOrdinary Share
Fiscal year-endApr 07
Address1200 Summit Avenue
CityFORT WORTH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code76102
Phone18175292300
Websitehttps://sanaramedtech.com/
Ticker SymbolSMTI
IPO dateApr 07, 1994
CEOMuppalla (Suresh V)
Company Executives of Sanara Medtech Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
Shareholding Stats
Updated: Fri, Dec 5
Updated: Fri, Dec 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
Other
36.61%
Shareholders
Shareholders
Proportion
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
Other
36.61%
Shareholder Types
Shareholders
Proportion
Corporation
45.04%
Individual Investor
20.27%
Investment Advisor
6.43%
Investment Advisor/Hedge Fund
4.42%
Research Firm
0.98%
Hedge Fund
0.78%
Bank and Trust
0.11%
Pension Fund
0.11%
Other
21.85%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
109
1.11M
12.48%
-19.18K
2025Q2
125
6.82M
76.76%
+464.64K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
FA Sanara, L.L.C.
3.51M
39.45%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.86%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.76%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.51%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
175.98K
1.98%
-20.48K
-10.43%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
187.10K
2.1%
-6.12K
-3.17%
Jun 30, 2025
Stonebridge Wealth Management, LLC
119.66K
1.34%
+19.60K
+19.59%
Jun 30, 2025
Yon (Seth D)
89.85K
1.01%
+28.56K
+46.60%
Sep 15, 2025
Geode Capital Management, L.L.C.
77.74K
0.87%
-11.01K
-12.41%
Jun 30, 2025
Marshall Wace LLP
71.51K
0.8%
+42.24K
+144.28%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Texas Capital Texas Small Cap Equity Index ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
View more
Texas Capital Texas Small Cap Equity Index ETF
Proportion0.05%
WisdomTree US SmallCap Fund
Proportion0.03%
iShares Micro-Cap ETF
Proportion0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Sanara Medtech Inc?
The top five shareholders of Sanara Medtech Inc are:
FA Sanara, L.L.C. holds 3.51M shares, accounting for 39.45% of the total shares.
Stuckert (James W) holds 966.97K shares, accounting for 10.86% of the total shares.
Tall Pines Capital LLC holds 512.87K shares, accounting for 5.76% of the total shares.
Howell (Solomon Oden Jr) holds 490.39K shares, accounting for 5.51% of the total shares.
The Vanguard Group, Inc. holds 175.98K shares, accounting for 1.98% of the total shares.
FA Sanara, L.L.C. holds 3.51M shares, accounting for 39.45% of the total shares.
Stuckert (James W) holds 966.97K shares, accounting for 10.86% of the total shares.
Tall Pines Capital LLC holds 512.87K shares, accounting for 5.76% of the total shares.
Howell (Solomon Oden Jr) holds 490.39K shares, accounting for 5.51% of the total shares.
The Vanguard Group, Inc. holds 175.98K shares, accounting for 1.98% of the total shares.
What are the top three shareholder types of Sanara Medtech Inc?
The top three shareholder types of Sanara Medtech Inc are:
FA Sanara, L.L.C.
Stuckert (James W)
Tall Pines Capital LLC
FA Sanara, L.L.C.
Stuckert (James W)
Tall Pines Capital LLC
How many institutions hold shares of Sanara Medtech Inc (SMTI)?
As of 2025Q3, 109 institutions hold shares of Sanara Medtech Inc, with a combined market value of approximately 1.11M, accounting for 12.48% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -64.28%.
What is the biggest source of revenue for Sanara Medtech Inc?
In FY2025Q2, the Soft tissue repair products business generated the highest revenue for Sanara Medtech Inc, amounting to 22.66M and accounting for 87.73% of total revenue.
